ReviewInternational journal of molecular sciences2025
Anthozoan Chemical Defenses: Integrating Compounds, Enzymatic Activities, and Omics-Based Discoveries.
Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Whole-genome analysis of Brevibacterium sanguinis AZMABM HM27: a bacterial isolate from the sea anemone Radianthus magnifica and exhibiting promising multi-therapeutic properties.Molecular biology reports · 2026Article
- Antioxidant, Anti-Inflammatory and Anticancer Peptides from Extreme Marine Environments.Antioxidants (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anthozoa is a species-rich class with an innate immune system that acts as a defensive tool and shares many of its cellular pathways with mammalian immune responses. In addition to immune-related strategies (e.g., allorecognition and xenorecognition), anthozoans have evolved to use compounds or toxins for chemical communication, defense, or predation, which may exhibit biological activities useful for human health, mainly antiviral, antibacterial, anti-inflammatory, anticancer, and antitumor properties of pharmaceutical interest. These compounds/toxins can be alkaloids, amino acids, proteins, ceramides, diterpenes, and sesquiterpenes and are mainly distributed into Hexacorallia and Octocorallia. Anthozoans are enriched in defensive enzymes, which can either be found in anthozoan species or their symbionts and help them survive in hostile conditions. Studies related to genomics and transcriptomics using advanced sequencing efforts revealed the presence of genetic elements in anthozoans that help them survive against abiotic and biotic stressors in the marine environment. This review presents developments and highlights the current state of knowledge about anthozoans' chemical weaponry that can drive further bioprospection of anthozoan species producing compounds and toxins which may be useful in biotechnological applications. Omics research in Anthozoa is still nascent, and more efforts are required to fully understand the chemical ecology, diversity, and possible biotechnological applications of cnidarian genes and their products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.